Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
2'-C-Methylcytidine
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/29/2020
Efonidipine
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/25/2020
MB_266
Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020
MB_250
Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020
MB_241
Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020
(1,3-Dimethylpyrazol-4-yl)-[4-(4-fluorophenyl)piperazin-1-yl]methanone
Potential treatment - theoretical effect Experimental Antiviral Oct/23/2020
Ac-QS5-VS
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/22/2020
ACE2 receptor trap
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/22/2020
Xuanfei Baidu decoction
Potential treatment - clinical evidence Experimental Unknown Oct/21/2020
SATPdb18674
Potential treatment - theoretical effect Experimental Antiviral Oct/21/2020
VH3 B01
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
VH2 A01-B01
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
VH2 A01-B02
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
SARS-CoV-2 HRC lipopeptide
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
VHH-Fcs 1B-3F-2A
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
VHH-Fcs 3F-1B-2A
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
1-Benzyl-3-[[3-[3-[4-[4-(hydroxymethyl)phenyl]-6-[(4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3-dioxan-2-yl]phenyl]phenyl]methyl]urea
Potential treatment - theoretical effect Experimental Antiviral Oct/20/2020
N-[3-[4-[4-(Hydroxymethyl)phenyl]-6-[[2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]methyl]-1,3-dioxan-2-yl]phenyl]acetamide
Potential treatment - theoretical effect Experimental Antiviral Oct/20/2020
Aclarubicin
Potential treatment - theoretical effect Experimental Antiviral Oct/19/2020
Faldaprevir
Potential treatment - theoretical effect Experimental Antiviral Oct/19/2020